Tropomyosin-related Kinase B Is Potentially a Biomarker of Prognosis and Therapeutic Target for Malignant Thymic Epithelial Tumors.
Anticancer Res
; 42(8): 3779-3787, 2022 Aug.
Article
in En
| MEDLINE
| ID: mdl-35896228
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thymoma
/
Thymus Neoplasms
/
Carcinoma
/
Neoplasms, Glandular and Epithelial
/
Receptor, trkB
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Anticancer Res
Year:
2022
Document type:
Article
Affiliation country:
Japan
Country of publication:
Greece